Top

Published in:

01-10-2012 | CARDIOVASCULAR DISEASE

Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies

Authors: Jenny Hansson, Maria Rosaria Galanti, Maria-Pia Hergens, Peeter Fredlund, Anders Ahlbom, Lars Alfredsson, Rino Bellocco, Marie Eriksson, Johan Hallqvist, Bo Hedblad, Jan-Håkan Jansson, Peter Nilsson, Nancy Pedersen, Ylva Trolle Lagerros, Per-Olof Östergren, Cecilia Magnusson

Published in: European Journal of Epidemiology | Issue 10/2012

Abstract

The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is common in Sweden and increasing elsewhere, is receiving increasing attention since considered a tobacco smoke “potential reduction exposure product”. Snus delivers a high dose of nicotine with possible hemodynamic effects, but its impact on cardiovascular morbidity and mortality is uncertain. The aim of this study was to investigate whether snus use is associated with risk of and survival after acute myocardial infarction (AMI). Data from eight prospective cohort studies set in Sweden was pooled and reanalysed. The relative risk of first time AMI and 28-day case-fatality was calculated for 130,361 men who never smoked. During 2,262,333 person-years of follow-up, 3,390 incident events of AMI were identified. Current snus use was not associated with risk of AMI (pooled multivariable hazard ratio 1.04, 95 % confidence interval 0.93 to 1.17). The short-term case fatality rate appeared increased in snus users (odds ratio 1.28, 95 % confidence interval 0.99 to 1.68). This study does not support any association between use of snus and development of AMI. Hence, toxic components other than nicotine appear implicated in the pathophysiology of smoking related ischemic heart disease. Case fatality after AMI is seemingly increased among snus users, but this relationship may be due to confounding by socioeconomic or life style factors.

Lambe M. Swedish snus for tobacco harm reduction. Lancet. 2007;370(9594):1206–7. (1206; author reply).PubMedCrossRef

Foulds J, Kozlowski L. Snus–what should the public-health response be? Lancet. 2007;369(9578):1976–8.PubMedCrossRef

European Commission. Health effects of smokeless tobacco products: Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Brussels. 2007.

Holm LE, Fisker J, Larsen BI, Puska P, Halldorsson M. Snus does not save lives: quitting smoking does! Tob control. 2009;18(4):250–1.PubMedCrossRef

Stenbeck M, Hagquist C, Rosen M. The association of snus and smoking behaviour: a cohort analysis of Swedish males in the 1990s. Addiction (Abingdon, England). 2009;104(9):1579–85.CrossRef

Gilljam H, Galanti MR. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction (Abingdon, England). 2003;98(9):1183–9.CrossRef

Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008;9(7):667–75.PubMedCrossRef

Nordenvall C, Nilsson PJ, Ye W, Nyren O. Smoking, snus use and risk of right- and left-sided colon, rectal and anal cancer: a 37-year follow-up study. Int J Cancer. 2011;128(1):157–65.PubMedCrossRef

England LJ, Levine RJ, Mills JL, Klebanoff MA, Yu KF, Cnattingius S. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol. 2003;189(4):939–43.PubMedCrossRef

10.

Wikstrom AK, Cnattingius S, Galanti MR, Kieler H, Stephansson O. Effect of Swedish snuff (snus) on preterm birth. BJOG. 2010;117(8):1005–10.PubMedCrossRef

11.

Wikstrom AK, Cnattingius S, Stephansson O. Maternal use of Swedish snuff (snus) and risk of stillbirth. Epidemiology (Cambridge, Mass). 2010;21(6):772–8.CrossRef

12.

Holm H, Jarvis MJ, Russell MA, Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology. 1992;108(4):507–11.PubMedCrossRef

13.

Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Prev Med. 1997;26(4):412–7.PubMedCrossRef

14.

Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ (Clinical research ed.). 1992;305(6864):1252–6.CrossRef

15.

Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol. 1999;34(6):1784–90.PubMedCrossRef

16.

Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology (Cambridge, Mass). 2005;16(1):12–6.CrossRef

17.

Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil. 2005;12(4):387–92.PubMedCrossRef

18.

Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med. 2007;262(3):351–9.PubMedCrossRef

19.

Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med. 2007;262(3):360–7.PubMedCrossRef

20.

Haglund B, Eliasson M, Stenbeck M, Rosen M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J public Health. 2007;35(6):618–22.PubMedCrossRef

21.

Hansson J, Pedersen NL, Galanti MR, Andersson T, Ahlbom A, Hallqvist J, Magnusson C. Use of snus and risk for cardiovascular disease: results from the Swedish Twin Registry. J Intern Med. 2009;265(6):717–24.PubMedCrossRef

22.

Janzon E, Hedblad B. Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC Cardiovasc Disord. 2009;9:21.PubMedCrossRef

23.

Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994;84(3):399–404.PubMedCrossRef

24.

Carlsson F, Merlo J, Lindstrom M, Ostergren PO, Lithman T. Representativity of a postal public health questionnaire survey in Sweden, with special reference to ethnic differences in participation. Scand J public health. 2006;34(2):132–9.PubMedCrossRef

25.

Eriksson M, Holmgren L, Janlert U, Jansson JH, Lundblad D, Stegmayr B, Soderberg S, Eliasson M. Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986–2009. J Intern Med. 2011;269(2):219–31.PubMedCrossRef

26.

Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G. The Malmo diet and cancer study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001;10(6):489–99.PubMedCrossRef

27.

Alfredsson L, Hammar N, Fransson E, de Faire U, Hallqvist J, Knutsson A, Nilsson T, Theorell T, Westerholm P. Job strain and major risk factors for coronary heart disease among employed males and females in a Swedish study on work, lipids and fibrinogen. Scand J Work Environ Health. 2002;28(4):238–48.PubMedCrossRef

28.

Bellocco R, Jia C, Ye W, Lagerros YT. Effects of physical activity, body mass index, waist-to-hip ratio and waist circumference on total mortality risk in the Swedish National March Cohort. Eur J Epidemiol. 2010;25(11):777–88.PubMedCrossRef

29.

Lichtenstein P, Sullivan PF, Cnattingius S, Gatz M, Johansson S, Carlstrom E, Bjork C, Svartengren M, Wolk A, Klareskog L, et al. The Swedish Twin Registry in the third millennium: an update. Twin Res Hum Genet. 2006;9(6):875–82.PubMedCrossRef

30.

Hansson J, Galanti MR, Magnusson C, Hergens MP. Weight gain and incident obesity among male snus users. BMC Public Health. 2011;11:371.PubMedCrossRef

31.

Norberg M, Wall S, Boman K, Weinehall L. The vasterbotten intervention programme: background, design and implications. Glob Health Action. 2010; 3:4643. doi:10.3402/gha.v3i0.4643.

32.

Eliasson M, Asplund K, Evrin PE, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis. 1995;113(1):41–53.PubMedCrossRef

33.

Lundqvist G, Sandstrom H, Ohman A, Weinehall L. Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population. Scand J Public Health. 2009;37(2):161–7.PubMedCrossRef

34.

Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K. Evolving patterns of tobacco use in northern Sweden. J Intern Med. 2003;253(6):660–5.PubMedCrossRef

35.

Furberg H, Lichtenstein P, Pedersen NL, Bulik C, Sullivan PF. Cigarettes and oral snuff use in Sweden: prevalence and transitions. Addiction (Abingdon, England). 2006;101(10):1509–15.CrossRef

36.

Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol. 2001;30(Suppl 1):S30–4.PubMedCrossRef

37.

Lee PN. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol. 2007;36(4):789–804.PubMedCrossRef

38.

Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ (Clinical research ed.). 2009;339:b3060.

39.

Galobardes B, Lynch J, Smith GD. Measuring socioeconomic position in health research. Br Med Bull. 2007;81–82:21–37.PubMedCrossRef

40.

Peltonen M, Rosen M, Lundberg V, Asplund K. Social patterning of myocardial infarction and stroke in Sweden: incidence and survival. Am J Epidemiol. 2000;151(3):283–92.PubMedCrossRef

41.

Engström K, Magnusson C, Galanti MR. Socio-demographic, lifestyle and health characteristics among snus users and dual tobacco users in Stockholm County Sweden. BMC Public Health. 2010;10:619.PubMedCrossRef

42.

Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction (Abingdon, England). 2000;95(10):1505–23.CrossRef

43.

Yashima M, Ohara T, Cao JM, Kim YH, Fishbein MC, Mandel WJ, Chen PS, Karagueuzian HS. Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction. Am J Physiol Heart Circ Physiol. 2000;278(6):H2124–33.PubMed

44.

Ohara T, Yashima M, Hamzei A, Favelyukis M, Park A, Kim YH, Mandel WJ, Chen PS, Karagueuzian HS. Nicotine Increases Spatiotemporal Complexity of Ventricular Fibrillation Wavefront on the Epicardial Border Zone of Healed Canine Infarcts. J Cardiovasc Pharmacol Ther. 1999;4(2):121–7.PubMedCrossRef

45.

Mehta MC, Jain AC, Mehta A, Billie M. Cardiac Arrhythmias Following Intravenous Nicotine: experimental Study in Dogs. J Cardiovasc Pharmacol Ther. 1997;2(4):291–8.PubMedCrossRef

46.

Martin JS, Beck DT, Gurovich AN, Braith RW. The acute effects of smokeless tobacco on central aortic blood pressure and wave reflection characteristics. Exp Biol Med (Maywood). 2010;235(10):1263–8.CrossRef

Title: Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies
Authors: Jenny Hansson
Maria Rosaria Galanti
Maria-Pia Hergens
Peeter Fredlund
Anders Ahlbom
Lars Alfredsson
Rino Bellocco
Marie Eriksson
Johan Hallqvist
Bo Hedblad
Jan-Håkan Jansson
Peter Nilsson
Nancy Pedersen
Ylva Trolle Lagerros
Per-Olof Östergren
Cecilia Magnusson
Publication date: 01-10-2012
Publisher: Springer Netherlands
Published in: European Journal of Epidemiology / Issue 10/2012
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-012-9704-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2012

Prevalence of type 2 diabetes in Germany in 2040: estimates from an epidemiological model

Leukemia risk in children exposed to benzene and PM10 from vehicular traffic: a case–control study in an Italian population

Kenneth J. Rothman: Epidemiology. An introduction

From infancy to pregnancy: birth weight, body mass index, and the risk of gestational diabetes

Association between alcohol consumption in healthy midlife and telomere length in older men. The Helsinki Businessmen Study

Assessing the discriminative ability of risk models for more than two outcome categories